Summary
Bristol Myers Squibb Co.'s 1996 10-K filing indicates a company in the pharmaceutical sector focused on the development, manufacturing, and marketing of prescription drugs. The filing covers the fiscal year ending December 30, 1996, and was submitted on March 31, 1997. Investors should note the company's commitment to research and development as a key driver for future growth, as is typical for pharmaceutical firms. Specific financial performance, product pipeline details, and any significant legal or regulatory matters from this period would be crucial for a comprehensive understanding of the company's standing at that time.
Key Highlights
- 1The filing pertains to Bristol Myers Squibb Co. for the fiscal year ending December 30, 1996.
- 2It was officially filed with the SEC on March 31, 1997.
- 3The company operates within the pharmaceutical industry.
- 4Key focus areas for pharmaceutical companies include research and development (R&D) to fuel future product pipelines.
- 5Manufacturing and marketing of prescription drugs are core business activities.
- 6This report provides insights into the company's financial health and operational status as of the end of 1996.